ARTICLE | Company News
Chelsea Therapeutics, Lundbeck deal
June 2, 2014 7:00 AM UTC
H. Lundbeck began its tender offer to acquire Chelsea for up to $7.94 per share, or about $626.8 million. Chelsea shareholders will receive $6.44 per share in cash, or about $508.3 million, and a cont...